Clinical Significance of PD ‐ L1 and HLA Expression in Esophageal Squamous Cell Carcinoma in Response to Immunotherapy

Documenti analoghi

• Intratumoral Fusobacterium nucleatum Drives Cancer‐Associated Fibroblasts Enrichment and Immune Exclusion in Esophageal Squamous Cell Carcinoma
  di: Takashi Ofuchi, et al.
  Pubblicazione: (2025)
• Textbook outcome contributes to long‐term prognosis in elderly patients with esophageal squamous cell carcinoma
  di: Chihiro Matsumoto, et al.
  Pubblicazione: (2024)
• Advances in Gastric Cancer Research: Insights Into Carcinogenesis, the Tumor Microenvironment, Metastasis, and Factors Influencing Prognosis
  di: Hideo Baba, et al.
  Pubblicazione: (2026)
• Essential Updates 2024–2025: Surgical Strategy for Esophageal Cancer Toward a New Paradigm in the Era of Immunotherapy and Personalization
  di: Shuichiro Oya, et al.
  Pubblicazione: (2026)
• Response to “Letter to the Editor Regarding Prognostic Impact of Hepatectomy Versus Radiofrequency Ablation for Non‐Small Hepatocellular Carcinoma (2–3 cm): A Case‐Matched Study”
  di: Yuki Kitano, et al.
  Pubblicazione: (2025)